Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The overall goal of the proposed study is to use digital phenotyping to identify and triage at-risk patients and accelerate access to critical mental health services.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Digital Phenotyping Arm | Experimental | All participants (adolescents and young adults with cancer) will receive the digital phenotyping intervention, which includes wearing a smartwatch and using a smartphone-based EMA app over a 10-day period, with psychosocial assessments at baseline, day 10, and 2 months |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Device | Device | Participants will wear a wrist-based wearable device for 10 days to passively track physiological data (heart rate, steps, sleep, etc.). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Depressive Symptoms (Beck Depression Inventory - BDI) | The Beck Depression Inventory-II (BDI-II; range 0-63) will be used to measure changes in depressive symptoms among adolescents and young adults over time. Higher scores indicate greater depressive symptom severity. | Baseline, Day 10, 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Participant Retention Rate (MyPHD App and Wearable Device) | Percentage of participants who remain active in the study through the 2-month follow-up period using the MyPHD app and wearable device. | Baseline to 2 months |
| Adherence to EMA Prompts |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Olivia Borge | Contact | (650) 723-9392 | oborge@stanford.edu |
| Name | Affiliation | Role |
|---|---|---|
| Victoria Cosgrove, PhD | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University | Recruiting | Palo Alto | California | 94304 | United States |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004864 | Equipment and Supplies |
| D000072860 | Ecological Momentary Assessment |
| ID | Term |
|---|---|
| D011581 | Psychological Tests |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App | Behavioral | Participants will respond to ecological momentary assessments (EMA) via smartphone to actively report on sleep, mood, stress, and eating habits across a 10-day period. |
|
Mean percentage of EMA prompts completed by participants using the MyPHD mobile app during the 2-month study period. Completion will be assessed via EMA system analytics.
| Baseline to 2 months |
| Wearable Device Return and Use Rate | Percentage of participants who return and use the wearable device as instructed during the study period. Device use will be tracked through backend device usage logs. | Baseline to 2 months |
| Change in Anxiety Symptoms (Beck Anxiety Inventory - BAI) | Measures changes in self-reported anxiety symptoms across the study period. | Baseline, Day 10, 2 months |
| Change in PTSD Symptoms (CROPS) | PTSD symptoms are measured using the Child Report of Post-traumatic Symptoms (CROPS) for child participants. | Baseline |
| Change in PTSD Symptoms (PCL-5) | PTSD symptoms are measured using the PTSD Checklist for DSM-5 (PCL-5) for general population participants. | Baseline |
| Change in Sleep Quality (Pittsburgh Sleep Quality Index - PSQI) | Assesses subjective sleep quality and patterns. | Baseline, Day 10 |